Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cranford, New Jersey
- Most recent report
- 8-K, filed Nov 4, 2026
- Incorporated
- Delaware
- Filings on record
- 268 filings
- On EDGAR
- CIK 1851484
- Fiscal year ends
- September
- Filer status
- Emerging growth company
Financials 8 of 17
News 8 of 55
Prospectuses and Registrations 8 of 36
- 424B3 Prospectus supplement for an offering Aug 14, 2026
- 424B3 Prospectus supplement for an offering Aug 5, 2026
- 424B3 Prospectus supplement for an offering Jun 1, 2026
- S-3 Shelf registration statement May 29, 2026
- 424B3 Prospectus supplement for an offering May 22, 2026
- 424B3 Prospectus supplement for an offering May 6, 2026
- 424B3 Prospectus supplement for an offering May 5, 2026
- POS AM Post-effective amendment to a registration Feb 20, 2026
Proxies 5
Ownership 8 of 94
- 3 Insider reported their initial holding Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Jun 4, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Feb 17, 2026
- 4/A Insider reported a trade, amended Dec 22, 2025
- 4/A Insider reported a trade, amended Dec 22, 2025
- 4/A Insider reported a trade, amended Dec 22, 2025
Other 8 of 61
- ARS Annual report sent to shareholders Aug 26, 2026
- EFFECT Notice that a registration became effective Jun 5, 2026
- CORRESP Reply to SEC staff Jun 3, 2026
- UPLOAD Comment letter from SEC staff Jun 3, 2026
- DEF 14C May 29, 2026
- PRE 14C May 19, 2026
- EFFECT Notice that a registration became effective Mar 2, 2026
- DEF 14C Jan 29, 2026
Everything here comes from Citius Oncology, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.